Found 27 matching trials
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects
PHASE1This study is an open-label, randomized, fed, single dose, crossover study ...
Location
Korea University Anam Hospital
Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308
PHASE1Phase 1 trial to evaluate the drug drug interaction of CKD-501 and D308...
Location
Chonbuk National University Hospital
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
PHASE4To assess the efficacy of treatment with sitagliptin or dapagliflozin or lo...
Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
PHASE3The purpose of this study is to prove effect of glucose reduction that CKD-...
Location
Kangbuk Samsung Hospital
CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
PHASE1The purpose of this study is to evaluate a pharmacokinetic drug interaction...
Location
Chonbuk National University Hospital
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
PHASE1This study is a randomized, open-label, single dose, 2-way crossover study ...
Location
Chonbuk National University Hospital
Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
PHASE3The purpose of this study is to prove that the group treated with CKD-501 i...
Location
Severance Hospital, Yonsei University Health System
Efficacy and Safety of Lobeglitazone Versus Sitagliptin
PHASE4Efficacy and Safety of Lobeglitazone versus Sitagliptin in inadequately con...
Location
Korea University Anam Hospital
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.
PHASE1This is a Randomized, open-label, single oral dosing, two-sequence, and two...
Location
Chung-Ang University Gwangmyeong Hospital
Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
PHASE3The purpose of this study is to prove that the group treated with CKD-501 i...
Location
Severance Hospital, Yonsei University Health System